Joshua A. Hill

Dr. Joshua Hill is an Associate Professor in the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center, with a joint appointment in the Department of Medicine at University of Washington. As a physician-scientist, he specializes in treating infectious diseases in cancer patients, transplant recipients, and immunocompromised individuals.

Education:

• BA, Liberal Arts & Natural Sciences, University of Texas at Austin, 2005
• MD, University of Texas Southwestern Medical Center, 2009
• Residency, Internal Medicine, Brigham and Women’s Hospital, 2009-2012
• Fellowship, Infectious Diseases, University of Washington, 2012-2015
• Fellowship, Epidemiology, Harvard School of Public Health, 2013

Research: Leads clinical trials for novel infection therapies targeting viral pathogens like HHV-6 in immunocompromised populations, particularly CAR-T cell recipients. His epidemiological work focuses on infection risks in novel immunotherapies through the ImmunOptimize Network. Research employs multidisciplinary collaboration with virologists, oncologists, and statisticians.

Awards:

• FIDSA recognition (2021)
• Multiple NIH career development awards
• American Society for Blood and Marrow Transplantation honors

Clinical Leadership: Serves as attending physician at Fred Hutch and directs the Hill Group, studying infection epidemiology in vulnerable populations. Currently conducting trials on IVIG therapy post-CAR-T treatment and COVID-19 vaccines for hematologic malignancies.